Genetic and antigenic diversity of Ehrlichia chaffeensis: Comparative analysis of a novel human strain from Oklahoma and previously isolated strains

Journal of Infectious Diseases

Volumn 175, Issue 4, 1997, Pages 856-863

  Chen, Sheng Min ^b   Yu, Xue Jie ^b   Popov, Vsevolod L ^b   Westerman, Eric L ^b   Hamilton, Frank G ^b   Walker, David H ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA;

AGED; ARTICLE; BACTERIAL GENETICS; BACTERIUM ISOLATION; BIODIVERSITY; CASE REPORT; DNA SEQUENCE; EHRLICHIA; EHRLICHIOSIS; HUMAN; IMMUNOBLOTTING; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030971443     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513982     Document Type: Article

References (25)

1. Anderson BE, Dawson JE, Jones DC, Wilson KH. Ehrlichia chaffeensis, a new species associated with human ehrlichiosis. J Clin Microbiol 1991;29:2838-42.
2. Dawson JS, Anderson BE, Fishbein DB, et al. Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991;29:2741-5.
3. Bakken JS, Dumler JS, Chen SM, Eckman MR, Etta LV, Walker DH. Human granulocytic ehrlichiosis in the upper midwest United States: a new species emerging? JAMA 1994;272:212-8.
4. Chen SM, Dumler JS, Bakken JS, Walker DH. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol 1994;32:589-95.
5. Eng TR, Harkess JR, Fishbein DB, et al. Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988. JAMA 1990;264:2251-8.
6. Fishbein DB, Dawson JE, Robinson LE. Human ehrlichiosis in the United States, 1985 to 1990. Ann Intern Med 1994;120:736-43.
7. Morais JD, Dawson JE, Greene C, Filipe AR, Galhardas LC, Bacellar F. First European case of ehrlichiosis. Lancet 1991;338:633-4.
8. Uhaa IJ, MacLean JD, Greene CR, Fishbein DB. A case of human ehrlichiosis acquired in Mali: clinical and laboratory findings. Am J Trop Med Hyg 1992;46:161-4.
9. Walker DH, Barbour A, Oliver JH, et al. Emerging bacterial zoonotic and vector-borne diseases: prospects for their effects on the public health. JAMA 1995;275:463-9.
10. Dumler JE, Chen SM, Asanovich K, Trigiani E, Popov VL, Walker DH. Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with near-fatal ehrlichiosis. J Clin Microbiol 1995;33: 1704-11.
11. Chen SM, Popov VL, Feng HM, Walker DH. Analysis and ultrastructural localization of Ehrlichia chaffeensis proteins with monoclonal antibodies. Am J Trop Med Hyg 1996;54:405-12.
12. Chen SM, Dumler JS, Feng HM, Walker DH. Identification of the antigenic constituents of Ehrlichia chaffeensis. Am J Trop Med Hyg 1994;50: 52-8.
13. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
14. Chen SM, Popov VL, Feng HM, Walker DH. Cultivation of Ehrlichia chaffeensis in mouse embryo cells, Vero, BGM, and L929 cells and study of Ehrlichia-induced cytopathic effect and plaque formation. Infect Immun 1995;63:647-55.
15. Yu X, Brouqui P, Dumler JS, Raoult D. Detection of Ehrlichia chaffeensis in human tissue by using a species-specific monoclonal antibody. J Clin Microbiol 1993;31:3284-8.
16. Anderson BE, Sumner JW, Dawson JE, et al. Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction. J Clin Microbiol 1992;30:775-80.
17. Wilson KH, Blitchington RB, Greene RC. Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. J Clin Microbiol 1990; 28:1942-6.
18. Yu XJ, Valdes PC, Walker DH. Cloning and sequencing of the gene for a 120-kDa immunodominant protein of Ehrlichia chaffeensis. Gene 1997;184:149-54.
19. Yu XJ, Crocquet-Valdes P, Cullman LC, Piesman JF, Olson JG, Walker DH. Genetic diversity of a 120-kDa immunodominant protein of Ehrlichia chaffeensis: a potential recombinant diagnostic tool. In: Kazár J, Toman R, eds. Rickettsiae and rickettsial diseases. Bratislava, Slovak Republic: Slovak Academy of Sciences, 1996:324-8.
20. Popov VL, Chen SM, Feng HM, Walker DH. Ultrastructural variation of Ehrlichia chaffeensis in cell culture. J Med Microbiol 1995;43:411-21.
21. Brouqui P, Raoult D. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans, Ehrlichia chaffeensis. Antimicrob Agents Chemother 1992;36:2799-803.
22. Dunn BE, Monson TP, Dumler JS, et al. Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol 1992;30:2207-10.
23. Woese CR. Bacterial evolution. Microbiol Rev 1987;51:221-71.
24. Goodman JL, Nelson C, Vitale B, et al. Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med 1996;334:209-15.
25. Rikihisa Y, Zhi N, Wormser G, Wen B, Horowitz HW, Hechemy KE. Direct isolation and cultivation of human granulocytotropic ehrlichia from a human patient [abstract 54]. In: Program and abstracts of the 12th sesquiannual meeting of the American Society for Rickettsiology and Rickettsial Diseases, Pacific Grove, CA, 1996:54.